Resolution: standard / high
Figure 1.
Antitumor activity against murine melanoma B16-F10 in C57BL/6 mice following TGIK administration via different routes of administration.
Hill et al. Journal of Immune Based Therapies and Vaccines 2005 3:5 doi:10.1186/1476-8518-3-5
Download authors' original image